Vaccines and Bell's palsy: A narrative review

Therapie. 2023 May-Jun;78(3):279-292. doi: 10.1016/j.therap.2022.07.009. Epub 2022 Aug 1.

Abstract

The association between vaccines and peripheral facial palsy (PFP), an issue that has been the subject of debate for many years, has been raised again following results of clinical trials assessing mRNA based COVID-19 vaccines. To review the available literature on this topic, PubMed was searched from inception until February 25, 2022. Inclusion criteria were case reports with documented rechallenge and comparative epidemiological studies. Cases of COVID-19 vaccine-induced PFP with available data on vaccine rechallenge were also identified from Vigibase until December 31, 2021. Of the 347 articles retrieved, 32 comparative epidemiological studies, 1 meta-analysis and 4 case reports met our criteria, of which 13 involved COVID-19 vaccines. Eight studies found an association between at least one vaccine and the occurrence of PFP, whereas 24 did not. Positive studies involved seasonal or pandemic H1N1 influenza vaccines administered parenterally (4 studies) or intranasally (1 study with a toxin-adjuvanted vaccine), BNT162b2, a mRNA COVID-19 vaccine (1 disproportionality analysis and 1 observed-to-expected analysis) and an inactivated virus COVID-19 vaccine (CoronaVac®) (1 study combining a case-control and an observed-to-expected approach). Strong evidence was found only for the intranasal influenza vaccine while other positive studies detected only a marginal association between PFP and vaccination. Of the four case reports with documented rechallenge, only two were positive and involved an influenza vaccine and tozinameran in one case each. In Vigibase, rechallenge was documented in 49 reports with 29 (59.2%) cases being negative and 20 (40.8%) positive. The available data did not confirm an excess risk of PFP after vaccination in most studies. Moreover, of the eight epidemiological studies suggesting a possible excess risk of PFP after any vaccine, three were disproportionality analyses and two observed-to excepted analyses, suggesting great caution should be taken when interpreting these results.

Keywords: Bell's palsy; COVID-19 vaccines; Facial paralysis; Immunization; Vaccination.

Publication types

  • Review
  • Meta-Analysis

MeSH terms

  • BNT162 Vaccine
  • Bell Palsy* / epidemiology
  • Bell Palsy* / etiology
  • COVID-19 Vaccines / adverse effects
  • COVID-19*
  • Facial Paralysis* / complications
  • Facial Paralysis* / drug therapy
  • Humans
  • Influenza A Virus, H1N1 Subtype*
  • Influenza Vaccines*

Substances

  • sinovac COVID-19 vaccine
  • COVID-19 Vaccines
  • Influenza Vaccines
  • BNT162 Vaccine